Inventor · disambiguated record
Lutz B. Giebel
Also filed as: GIEBEL LUTZ · GIEBEL LUTZ B
7 granted patents·2 pending applications·463 citations·filing 1992–2022
87Inventor score
Top patents by PatentIndex Score
9 records- 0196US5585275APilot apparatus for peptide synthesis and screeningARRIS PHARM CORP·Filed 1993·Granted Dec 17, 1996·207 cites·17 claims
- 0292US5576220AThin film HPMP matrix systems and methods for constructing and displaying ligandsARRIS PHARM CORP·Filed 1993·Granted Nov 19, 1996·115 cites·15 claims
- 0391US5591646AMethod and apparatus for peptide synthesis and screeningARRIS PHARMACEUTICAL·Filed 1992·Granted Jan 7, 1997·89 cites·25 claims
- 0479US6103879ABivalent molecules that form an activating complex with an erythropoietin receptorAXYS PHARM INC·Filed 1997·Granted Aug 15, 2000·46 cites·3 claims
- 0576US12365712B2Single-chain TNF Receptor 2 agonist fusion proteinsRELINIA INC·Filed 2022·Granted Jul 22, 2025·0 cites·7 claims
- 0676US11530247B2Single-chain TNF receptor 2 agonist fusion proteinsRELINIA INC·Filed 2018·Granted Dec 20, 2022·2 cites·20 claims
- 0755US2024358780A1Armed chimeric oncolytic virusesIMPLICYTE INC·Filed 2022·Application pending·0 cites
- 0854US2003177515A1Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses thereforARRIS PHARM CORP·Filed 2002·Application pending·0 cites
- 0934US6485964B1Transgenic mammals lacking expression of erythropoietin or of erythropoietin receptor, transgenic mammals expressing chimeric erythropoietin receptors, constructs for producing the transgenic mammals and uses thereforARRIS PHARM CORP·Filed 1997·Granted Nov 26, 2002·4 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Lutz B. Giebel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →